SCHEMBL8103313

SCHEMBL8103313

CC(C)COc1cc(C(=O)NS(=O)(=O)c2ccc(C(=O)NC3CCCCC3)cc2)cnc1OC(=O)O

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
TSHR P16473 3/20 0.45
HTT P42858 1/20 0.45
KMT2A Q03164 1/20 0.44
ALDH1A1 P00352 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
THRB P10828 1/20 0.42
BLM P54132 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA9 Q16790 1/20 0.41
GAA P10253 1/20 0.41
GFER P55789 1/20 0.41
NPC1 O15118 1/20 0.41
HPGD P15428 1/20 0.41
RAB9A P51151 1/20 0.41
SCN9A Q15858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8768228 0.93 LMNA (0.45) LMNASMN1; SMN2TSHRHTTKMT2A
SCHEMBL8767453 0.90 LMNA (0.42) LMNASMN1; SMN2TSHRHTTKMT2A
SCHEMBL8097853 0.89 LMNA (0.49) LMNASMN1; SMN2TSHRHTTKMT2A
SCHEMBL8873584 0.88 LMNA (0.47) LMNASMN1; SMN2TSHRHTTKMT2A
SCHEMBL8874073 0.86 LMNA (0.47) LMNASMN1; SMN2TSHRHTTKMT2A
SCHEMBL8767110 0.86 LMNA (0.40) LMNASMN1; SMN2TSHRHTTKMT2A
SCHEMBL8917593 0.84 L3MBTL1 (0.43) LMNASMN1; SMN2TSHRHTTKMT2A
SCHEMBL8875248 0.80 LMNA (0.41) LMNASMN1; SMN2TSHRHTTKMT2A
SCHEMBL8768360 0.80 L3MBTL1 (0.50) LMNASMN1; SMN2TSHRHTTKMT2A
SCHEMBL8097851 0.78 LMNA (0.51) LMNASMN1; SMN2TSHRHTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0673932-B1 Sulfonamidocarbonyl-pyridine-2-carboxamides as well as their pyridine-N-oxides, process for their preparation and their use as medicaments HOECHST AG (DE) 2000-06-07 EP disclosed
EP-0673931-B1 Sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicaments HOECHST AG (DE) 1997-08-13 EP disclosed
EP-0673931-A1 Sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicaments HOECHST AKTIENGESELLSCHAFT (DE) 1995-09-27 EP disclosed
EP-0673932-A1 Sulfonamidocarbonyl-pyridine-2-carboxamides as well as their pyridine-N-oxides, process for their preparation and their use as medicaments HOECHST AKTIENGESELLSCHAFT (DE) 1995-09-27 EP disclosed